Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198198040> ?p ?o ?g. }
- W3198198040 endingPage "205031212110422" @default.
- W3198198040 startingPage "205031212110422" @default.
- W3198198040 abstract "Antithrombotic agents are the basic therapeutic option for patients with arterial thrombosis who underwent percutaneous coronary intervention (PCI). In Bangladesh, aspirin and clopidogrel are frequently prescribed as antithrombotics or platelet inhibitors. Studies reported the genetic polymorphisms of CYP2C19*2, CYP2C19*17, and ITGB3 cause an alteration of the pharmacodynamic and pharmacokinetic profile of aspirin and clopidogrel. Therefore, we aimed to assess the prevalence of CYP2C19*2, CYP2C19*17, and ITGB3 polymorphisms among Bangladeshi patients with cardiovascular disease (CVD) who underwent PCI.Here we assessed a total of 1,000 CVD patients (male 782 and female 218) who underwent PCI and were treated with clopidogrel and/or aspirin. We performed genotyping of patients treated with clopidogrel and aspirin by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and tetra-primer amplification refractory mutation system PCR (T-ARMS-PCR) methods. The PCR products of clopidogrel-treated patients were screened with agarose gel electrophoresis and then digested with SmaI and NsiI-HF for CYP2C19*2 and CYP2C19*17, respectively. We genotyped aspirin-treated patients with T-ARMS-PCR for missense rs5918 (PlA1/A1) polymorphism of the ITGB3 gene. Then we ran the digested PCR products on 2% agarose gel electrophoresis to detect the mentioned polymorphisms.Among the clopidogrel-treated patients, we observed 64.1% polymorphism (hetero + mutant) of CYP2C19*2 (loss-of-function allele) and 22.7% (hetero + mutant) of CYP2C19*17 (gain-of-function allele). On the other hand, among the aspirin-treated patients, polymorphisms of ITGB3 were 84.1% homozygous (PlA1/A1), 15.6% heterozygous (PlA1/A2), and 0.3% mutant homozygous.In the present study, we observed a high prevalence of genetic polymorphisms of CYP2C19 and ITGB3 genes. Therefore, we recommend genotyping of CVD patients before prescribing clopidogrel or aspirin to prevent coagulation. Based on the genotyping study, the adjustment of doses or alternative generics might require to avoid therapeutic failure or toxicity in some cases." @default.
- W3198198040 created "2021-09-13" @default.
- W3198198040 creator A5007828638 @default.
- W3198198040 creator A5010852085 @default.
- W3198198040 creator A5029120590 @default.
- W3198198040 creator A5037173028 @default.
- W3198198040 creator A5050789180 @default.
- W3198198040 creator A5060072164 @default.
- W3198198040 creator A5063970775 @default.
- W3198198040 creator A5081651994 @default.
- W3198198040 creator A5083550960 @default.
- W3198198040 date "2021-01-01" @default.
- W3198198040 modified "2023-10-16" @default.
- W3198198040 title "Prevalence of CYP2C19 and ITGB3 polymorphisms among Bangladeshi patients who underwent percutaneous coronary intervention" @default.
- W3198198040 cites W103701910 @default.
- W3198198040 cites W104398217 @default.
- W3198198040 cites W1480729244 @default.
- W3198198040 cites W1484537339 @default.
- W3198198040 cites W1508125153 @default.
- W3198198040 cites W1568290973 @default.
- W3198198040 cites W1653920301 @default.
- W3198198040 cites W1972035765 @default.
- W3198198040 cites W1984239800 @default.
- W3198198040 cites W1985059672 @default.
- W3198198040 cites W1985191019 @default.
- W3198198040 cites W1993232626 @default.
- W3198198040 cites W2018416628 @default.
- W3198198040 cites W2024352468 @default.
- W3198198040 cites W2030352776 @default.
- W3198198040 cites W2036871414 @default.
- W3198198040 cites W2039527993 @default.
- W3198198040 cites W2040125044 @default.
- W3198198040 cites W2043299984 @default.
- W3198198040 cites W2052568053 @default.
- W3198198040 cites W2058055783 @default.
- W3198198040 cites W2061689857 @default.
- W3198198040 cites W2075511676 @default.
- W3198198040 cites W2078601367 @default.
- W3198198040 cites W2091094310 @default.
- W3198198040 cites W2092372657 @default.
- W3198198040 cites W2096300961 @default.
- W3198198040 cites W2105489963 @default.
- W3198198040 cites W2119186881 @default.
- W3198198040 cites W2121983699 @default.
- W3198198040 cites W2125943603 @default.
- W3198198040 cites W2144206796 @default.
- W3198198040 cites W2151989102 @default.
- W3198198040 cites W2159858918 @default.
- W3198198040 cites W2164119946 @default.
- W3198198040 cites W2169387542 @default.
- W3198198040 cites W2169664210 @default.
- W3198198040 cites W2297186318 @default.
- W3198198040 cites W2316315581 @default.
- W3198198040 cites W2404216384 @default.
- W3198198040 cites W2735960192 @default.
- W3198198040 cites W2780886463 @default.
- W3198198040 cites W2793753528 @default.
- W3198198040 cites W2943384022 @default.
- W3198198040 doi "https://doi.org/10.1177/20503121211042209" @default.
- W3198198040 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8404630" @default.
- W3198198040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34471538" @default.
- W3198198040 hasPublicationYear "2021" @default.
- W3198198040 type Work @default.
- W3198198040 sameAs 3198198040 @default.
- W3198198040 citedByCount "3" @default.
- W3198198040 countsByYear W31981980402023 @default.
- W3198198040 crossrefType "journal-article" @default.
- W3198198040 hasAuthorship W3198198040A5007828638 @default.
- W3198198040 hasAuthorship W3198198040A5010852085 @default.
- W3198198040 hasAuthorship W3198198040A5029120590 @default.
- W3198198040 hasAuthorship W3198198040A5037173028 @default.
- W3198198040 hasAuthorship W3198198040A5050789180 @default.
- W3198198040 hasAuthorship W3198198040A5060072164 @default.
- W3198198040 hasAuthorship W3198198040A5063970775 @default.
- W3198198040 hasAuthorship W3198198040A5081651994 @default.
- W3198198040 hasAuthorship W3198198040A5083550960 @default.
- W3198198040 hasBestOaLocation W31981980401 @default.
- W3198198040 hasConcept C104317684 @default.
- W3198198040 hasConcept C126322002 @default.
- W3198198040 hasConcept C135763542 @default.
- W3198198040 hasConcept C140840227 @default.
- W3198198040 hasConcept C2777628954 @default.
- W3198198040 hasConcept C2777849778 @default.
- W3198198040 hasConcept C2780400711 @default.
- W3198198040 hasConcept C31467283 @default.
- W3198198040 hasConcept C500558357 @default.
- W3198198040 hasConcept C526171541 @default.
- W3198198040 hasConcept C54355233 @default.
- W3198198040 hasConcept C62231903 @default.
- W3198198040 hasConcept C71924100 @default.
- W3198198040 hasConcept C86803240 @default.
- W3198198040 hasConcept C90924648 @default.
- W3198198040 hasConcept C98274493 @default.
- W3198198040 hasConceptScore W3198198040C104317684 @default.
- W3198198040 hasConceptScore W3198198040C126322002 @default.
- W3198198040 hasConceptScore W3198198040C135763542 @default.
- W3198198040 hasConceptScore W3198198040C140840227 @default.
- W3198198040 hasConceptScore W3198198040C2777628954 @default.